• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于检测生物流体中内源性聚集蛋白聚糖片段的免疫亲和液相色谱-串联质谱检测法:作为聚集蛋白聚糖酶活性和软骨降解的生物标志物的应用。

An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation.

机构信息

Pfizer Global Research & Development, Andover, MA 01810, USA.

出版信息

Anal Biochem. 2010 Nov 15;406(2):113-23. doi: 10.1016/j.ab.2010.06.044. Epub 2010 Jul 23.

DOI:10.1016/j.ab.2010.06.044
PMID:20603097
Abstract

The degradation of articular cartilage by aggrecanases (ADAMTS-4 and ADAMTS-5) plays a significant role in the pathology of osteoarthritis (OA). To monitor aggrecanase activity in OA, we have developed a sensitive, accurate, and versatile assay for detection of two specific cleavage sites on aggrecan. The assay uses an immunoaffinity-based liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to detect cleavage at the (374)ARGS site and the (1820)AGEG site. The dynamic range of the assay is more than three orders of magnitude, with interassay precision less than 15%. It has been successfully applied to various biological fluids and species, including rat, bovine, dog, and human. The assay has been analytically qualified for use in human urine and synovial fluid (SF). The limits of detection (LODs) for ARGS in urine and SF are 2.5 and 10 pg/ml, respectively, whereas the LOD for AGEG is 20 pg/ml in SF. Analysis of these biomarkers from OA subjects and normal healthy volunteers revealed a significant elevation of both markers in OA. Similarly, in a rat model of cartilage degradation, both ARGS and AGEG were elevated, demonstrating the utility of these biomarkers for translational research. These data suggest that the ARGS and AGEG biomarkers developed have potential as measures of aggrecanase activity in OA and may contribute to our understanding of OA pathology.

摘要

聚集蛋白聚糖酶(ADAMTS-4 和 ADAMTS-5)对关节软骨的降解在骨关节炎(OA)的病理学中起着重要作用。为了监测 OA 中的聚集蛋白聚糖酶活性,我们开发了一种灵敏、准确且多功能的检测方法,用于检测聚集蛋白聚糖上两个特定的切割位点。该测定法使用基于免疫亲和的液相色谱-串联质谱(LC-MS/MS)方法来检测(374)ARGS 位点和(1820)AGEG 位点的切割。该测定法的动态范围超过三个数量级,批间精密度小于 15%。它已成功应用于各种生物流体和物种,包括大鼠、牛、狗和人。该测定法已在人尿液和滑液(SF)中进行了分析验证。ARG 在尿液和 SF 中的检测限(LOD)分别为 2.5 和 10 pg/ml,而 AGEG 在 SF 中的 LOD 为 20 pg/ml。对 OA 患者和正常健康志愿者的这些生物标志物的分析显示,OA 患者的两种标志物均显著升高。同样,在软骨降解的大鼠模型中,ARG 和 AGEG 均升高,证明了这些生物标志物在转化研究中的应用。这些数据表明,开发的 ARGS 和 AGEG 生物标志物具有作为 OA 中聚集蛋白聚糖酶活性的测量指标的潜力,并可能有助于我们对 OA 病理学的理解。

相似文献

1
An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation.一种用于检测生物流体中内源性聚集蛋白聚糖片段的免疫亲和液相色谱-串联质谱检测法:作为聚集蛋白聚糖酶活性和软骨降解的生物标志物的应用。
Anal Biochem. 2010 Nov 15;406(2):113-23. doi: 10.1016/j.ab.2010.06.044. Epub 2010 Jul 23.
2
Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo.用于基质金属蛋白酶活性的II型胶原新表位(TIINE)生物标志物的发现与开发:从体外到体内
Anal Biochem. 2007 Feb 1;361(1):93-101. doi: 10.1016/j.ab.2006.10.034. Epub 2006 Nov 15.
3
Immunoaffinity liquid chromatography-tandem mass spectrometry detection of nitrotyrosine in biological fluids: development of a clinically translatable biomarker.免疫亲和液相色谱-串联质谱法检测生物体液中的硝基酪氨酸:一种具有临床可转化性生物标志物的开发
Anal Biochem. 2008 Sep 1;380(1):68-76. doi: 10.1016/j.ab.2008.05.019. Epub 2008 May 20.
4
Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine.开发一种新型临床生物标志物检测方法,用于检测和定量人滑液、血清和尿液中聚集蛋白水解酶生成的聚集蛋白片段。
Osteoarthritis Cartilage. 2010 Sep;18(9):1150-8. doi: 10.1016/j.joca.2010.06.011. Epub 2010 Jul 13.
5
Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine.用于定量检测II型胶原新表位肽的免疫亲和液相色谱-串联质谱分析法的临床验证:一种人类尿液中基质金属蛋白酶活性和骨关节炎的生物标志物
Anal Biochem. 2007 Oct 1;369(1):41-53. doi: 10.1016/j.ab.2007.05.002. Epub 2007 May 6.
6
Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.人类骨关节炎滑液和关节软骨中均含有聚糖酶和基质金属蛋白酶产生的聚集蛋白聚糖片段。
Osteoarthritis Cartilage. 2006 Feb;14(2):101-13. doi: 10.1016/j.joca.2005.07.018. Epub 2005 Sep 26.
7
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs.一种用于监测聚集酶活性的短期药效动力学模型:向大鼠注射单碘乙酸钠(MIA),并使用新型 ELISA 检测滑液中聚集蛋白聚糖新表位的释放。
Osteoarthritis Cartilage. 2010 Sep;18(9):1159-66. doi: 10.1016/j.joca.2010.02.019. Epub 2010 Jul 13.
8
Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.用于检测聚集蛋白聚糖酶产生的聚集蛋白聚糖片段的高特异性和高灵敏度夹心酶联免疫吸附测定法的开发与特性分析
Osteoarthritis Cartilage. 2006 Jul;14(7):702-13. doi: 10.1016/j.joca.2006.01.012. Epub 2006 Mar 20.
9
Calpain is involved in C-terminal truncation of human aggrecan.钙蛋白酶参与人聚集蛋白聚糖 C 端的截断。
Biochem J. 2010 Sep 15;430(3):531-8. doi: 10.1042/BJ20100591.
10
Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and chondroitin sulfate domains.人聚集蛋白水解酶产生的滑液片段水平在膝关节损伤后直接升高,这是由于在连接球和软骨素硫酸盐结构域的蛋白水解作用。
Osteoarthritis Cartilage. 2011 Aug;19(8):1047-57. doi: 10.1016/j.joca.2011.05.006. Epub 2011 May 25.

引用本文的文献

1
ADAMTS proteases in cardiovascular physiology and disease.ADAMTS 蛋白酶在心血管生理学和疾病中的作用。
Open Biol. 2020 Dec;10(12):200333. doi: 10.1098/rsob.200333. Epub 2020 Dec 23.
2
ESTABLISHING A LIVE CARTILAGE-ON-CARTILAGE INTERFACE FOR TRIBOLOGICAL TESTING.建立用于摩擦学测试的活软骨对软骨界面
Biotribology (Oxf). 2017 Mar;9:1-11. doi: 10.1016/j.biotri.2016.11.002. Epub 2016 Nov 30.
3
Extracorporeal Shockwave Therapy Enhances Expression of Pdia-3 Which Is a Key Factor of the 1α,25-Dihydroxyvitamin D 3 Rapid Membrane Signaling Pathway in Treatment of Early Osteoarthritis of the Knee.
体外冲击波疗法增强了 Pdia-3 的表达,而 Pdia-3 是 1α,25-二羟维生素 D3 快速膜信号通路在治疗膝早期骨关节炎中的关键因素。
Int J Med Sci. 2017 Sep 19;14(12):1220-1230. doi: 10.7150/ijms.20303. eCollection 2017.
4
Review of Soluble Biomarkers of Osteoarthritis: Lessons From Animal Models.骨关节炎可溶性生物标志物综述:来自动物模型的经验教训。
Cartilage. 2017 Jul;8(3):211-233. doi: 10.1177/1947603516656739. Epub 2016 Jul 7.
5
The role of aggrecan in normal and osteoarthritic cartilage.聚集蛋白聚糖在正常及骨关节炎软骨中的作用。
J Exp Orthop. 2014 Dec;1(1):8. doi: 10.1186/s40634-014-0008-7. Epub 2014 Jul 16.
6
Pre-Osteoarthritis: Definition and Diagnosis of an Elusive Clinical Entity.骨关节炎前期:一种难以捉摸的临床实体的定义与诊断
Cartilage. 2015 Jul;6(3):156-65. doi: 10.1177/1947603515586048.
7
Characterization of neopeptides in equine articular cartilage degradation.马关节软骨降解中新肽的特征分析。
J Orthop Res. 2016 Jan;34(1):106-20. doi: 10.1002/jor.22963. Epub 2015 Jul 7.
8
OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis.骨关节炎研究学会(OARSI)临床试验建议:骨关节炎临床试验中的可溶性生物标志物评估
Osteoarthritis Cartilage. 2015 May;23(5):686-97. doi: 10.1016/j.joca.2015.03.002.
9
Republished: Value of biomarkers in osteoarthritis: current status and perspectives.重新发表:骨关节炎生物标志物的价值:现状与展望。
Postgrad Med J. 2014 Mar;90(1061):171-8. doi: 10.1136/postgradmedj-2013-203726rep.
10
Value of biomarkers in osteoarthritis: current status and perspectives.骨关节炎生物标志物的价值:现状与展望。
Ann Rheum Dis. 2013 Nov;72(11):1756-63. doi: 10.1136/annrheumdis-2013-203726. Epub 2013 Jul 29.